Trulieve Closes $287.5 Million Financing With US-Based Investors
Trulieve Cannabis (CSE: TRUL) has closed its previously announced marketed public offering of shares, the first such offering available in the United States. The financing saw the firm raise gross proceeds of C$287.5 million.
The financing saw a total of 5.8 million subordinate voting shares of the issuer sold at a price of $50 per share, which includes the full exercise of the over-allotment option. No warrants were issued in connection with the financing.
Proceeds from the offering are to be used to fund business development as well as for general working capital purposes.
Trulieve Cannabis last traded at $50.36 on the CSE.
Information for this briefing was found via Sedar and Trulieve Cannabis Corp. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
As the founder of The Deep Dive, Jay is focused on all aspects of the firm. This includes operations, as well as acting as the primary writer for The Deep Dive’s stock analysis. In addition to The Deep Dive, Jay performs freelance writing for a number of firms and has been published on Stockhouse.com and CannaInvestor Magazine among others.
